Press Releases

All Releases
View Summary MannKind Corporation Reports 2016 Fourth Quarter and Full Year Financial Results
03/16/17
PDF 28.6 KB Add to Briefcase
View Summary MannKind Corporation and Charles Mattocks Announce "REVERSED"-America's First Docu-Series Tackling Diabetes
03/08/17
PDF 9.9 KB Add to Briefcase
View Summary MannKind Corporation Announces Upcoming Events
03/07/17
PDF 12.0 KB Add to Briefcase
View Summary MannKind Receives $16.7 Million From Sale of Valencia Property 
02/21/17
PDF 7.8 KB Add to Briefcase
View Summary MannKind Announces Launch of New Titration Pack and Field Force Expansion to Accelerate Afrezza® Growth
02/01/17
PDF 17.5 KB Add to Briefcase
View Summary MannKind Corporation to Hold Investor Conference Call on February 1, 2017
01/27/17
PDF 8.6 KB Add to Briefcase
View Summary MannKind Receives $30.6 Million From Sanofi
01/09/17
PDF 7.8 KB Add to Briefcase
View Summary MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference
01/05/17
PDF 8.5 KB Add to Briefcase
View Summary MannKind Announces Key Addition to Its Executive Management Ranks
01/04/17
PDF 10.0 KB Add to Briefcase
View Summary MannKind Receives $1 Million Milestone From RLS
01/03/17
PDF 8.2 KB Add to Briefcase
View Summary MannKind and Sanofi Reach Agreement on AFREZZA®
11/09/16
PDF 10.3 KB Add to Briefcase
View Summary MannKind Corporation Reports 2016 Third Quarter Financial Results
11/09/16
PDF 24.6 KB Add to Briefcase
View Summary MannKind Corporation to Hold 2016 Third Quarter Financial Results Conference Call on November 9, 2016
11/01/16
PDF 8.9 KB Add to Briefcase
View Summary MannKind Corporation to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
09/02/16
PDF 8.6 KB Add to Briefcase
View Summary Securities Class Action Against MannKind Dismissed
08/25/16
PDF 7.9 KB Add to Briefcase
View Summary MannKind Corporation Reports 2016 Second Quarter Financial Results
08/08/16
PDF 19.9 KB Add to Briefcase
View Summary MannKind Corporation to Hold 2016 Second Quarter Financial Results Conference Call on August 8, 2016
08/01/16
PDF 8.9 KB Add to Briefcase
View Summary Mannkind Assumes Responsibility for Distribution of Afrezza® and Launches Patient Reimbursement and Adherence Support Programs
08/01/16
PDF 21.0 KB Add to Briefcase
View Summary MannKind Corporation to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
07/08/16
PDF 8.6 KB Add to Briefcase
View Summary MannKind Announces Late-Breaking Data Demonstrating Faster Onset and Shorter Duration of Action Compared to Mealtime Insulins
06/12/16
PDF 25.6 KB Add to Briefcase
Showing 1-20 of 291 Page: 1 2 3 4 5 ... 15  Next 20
Add to Briefcase = add release to Briefcase

MNKD

Exchange:
NASDAQ GM and TASE(US Dollar)

Price: 1.89

Change: 0.06 (3.077%)

Volume: 1,024,069

Data as of
03/24/2017 04:00 PM ET .
Minimum 20 minute delay.

Refresh Quote >

Locations

Learn more about MannKind's offices in the United States

Learn More